Honasa Consumer Ltd

Honasa Consumer Ltd

Honasa Consumer Ltd. announced the strategic acquisition of a 58% majority stake in Fluence Pharma, a science-backed nutraceuticals company known for its patented Cyclical Nutrition Therapy and dermatologist network. This acquisition marks Honasa's entry into the high-growth nutraceuticals category, specifically targeting "inside-out" beauty, under a newly formed subsidiary, Honasa Health. Fluence Pharma reported ~INR 40 Crore revenue and over 20% EBITDA margin in FY26, and Honasa aims to leverage Fluence's science with its own brand-building and digital distribution capabilities.

Honasa Consumer Ltd

Honasa Consumer Ltd announced the acquisition of a 58% equity stake in Fluence Pharma Private Limited, a company offering condition-specific OTC supplements under brands like "Hair Fact, Skin Fact, and Pro Fact." The acquisition, valued at approximately ₹135 Crores enterprise value for the initial stake, strategically marks Honasa's entry into the high-growth nutraceuticals market, with plans to acquire the remaining 42% over the next 5-7 years. Additionally, Honasa will incorporate a wholly-owned subsidiary, 'Honasa Health Private Limited,' to manage its new B2C nutraceuticals operations.